Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations.

about

Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations.

Item

http://www.wikidata.org/entity/Q43456772

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cost-effectiveness of the Aero ...... agement of COPD exacerbations.

@en

Cost-effectiveness of the Aero ...... agement of COPD exacerbations.

@nl

type

Item

label

Cost-effectiveness of the Aero ...... agement of COPD exacerbations.

@en

Cost-effectiveness of the Aero ...... agement of COPD exacerbations.

@nl

prefLabel

Cost-effectiveness of the Aero ...... agement of COPD exacerbations.

@en

Cost-effectiveness of the Aero ...... agement of COPD exacerbations.

@nl

P1476

Cost-effectiveness of the Aero ...... agement of COPD exacerbations.

@en

P2093

Dominic P Coppolo

http://www.w3.org/2001/XMLSchema#string

Jason A Suggett

http://www.w3.org/2001/XMLSchema#string

Shoghag Khoudigian-Sinani

http://www.w3.org/2001/XMLSchema#string

Stacey Kowal

http://www.w3.org/2001/XMLSchema#string

P2860

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

Leveraging Real-World Evidence in Disease-Management Decision-Making with a Total Cost of Care Estimator

Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation

Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

COPD exacerbation frequency and its association with health care resource utilization and costs.

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.

Mycobacteria as a cause of infective exacerbation in bronchiectasis.

Positive expiratory pressure and oscillatory positive expiratory pressure therapies.

Factors associated with exacerbation in mild- to-moderate COPD patients

Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.

P304

3065-3073

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S143334

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29089755

http://www.w3.org/2001/XMLSchema#string

P932

5655131

http://www.w3.org/2001/XMLSchema#string